This study resulted in increased numbers of active circulating CD4 and CD8 T cells, and identified specific changes in serum cytokines and peripheral CD4 T cell subsets associated with capillary leak syndrome, the major toxicity of immunotoxin therapies. Here, CD4 is linked to capillary leak syndrome.